Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
The Journal of Biological Chemistry
|
May 29, 2000
The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2
W Stockinger, C Brandes, D Fasching, et al.
Neuron
|
April 1, 1996
Novel features of drosophila period Transcription revealed by real-time luciferase reporting
C Brandes, J D Plautz, R Stanewsky, et al.
Journal of Biological Rhythms
|
June 1, 1997
Quantitative analysis of Drosophila period gene transcription in living animals
J D Plautz, M Straume, R Stanewsky, et al.
Transplantation
|
June 1, 1993
Hepatitis C is a poor prognostic indicator in black kidney transplant recipients
C Fritsche, J C Brandes, S R Delaney, et al.
Plos One
|
September 16, 2014
Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC
Seth A Brodie, Courtney Lombardo, Ge Li, et al.
The Oncologist
|
May 3, 2013
Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis
Taofeek K Owonikoko, Camille Ragin, Zhengjia Chen, et al.
The Journal of Biological Chemistry
|
September 10, 2010
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53
A R M Ruhul Amin, Dongsheng Wang, Hongzheng Zhang, et al.
Cancer Metastasis Reviews
|
December 31, 2013
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
Sarah Derks, Arjen H G Cleven, Veerle Melotte, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 21, 2014
Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer
Seth A Brodie, Ge Li, Adam El-Kommos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2013
CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC
Rathi N Pillai, Seth A Brodie, Gabriel L Sica, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
The Journal of Biological Chemistry
|
May 29, 2000
The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2
W Stockinger, C Brandes, D Fasching, et al.
Neuron
|
April 1, 1996
Novel features of drosophila period Transcription revealed by real-time luciferase reporting
C Brandes, J D Plautz, R Stanewsky, et al.
Journal of Biological Rhythms
|
June 1, 1997
Quantitative analysis of Drosophila period gene transcription in living animals
J D Plautz, M Straume, R Stanewsky, et al.
Transplantation
|
June 1, 1993
Hepatitis C is a poor prognostic indicator in black kidney transplant recipients
C Fritsche, J C Brandes, S R Delaney, et al.
Plos One
|
September 16, 2014
Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC
Seth A Brodie, Courtney Lombardo, Ge Li, et al.
The Oncologist
|
May 3, 2013
Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis
Taofeek K Owonikoko, Camille Ragin, Zhengjia Chen, et al.
The Journal of Biological Chemistry
|
September 10, 2010
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53
A R M Ruhul Amin, Dongsheng Wang, Hongzheng Zhang, et al.
Cancer Metastasis Reviews
|
December 31, 2013
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
Sarah Derks, Arjen H G Cleven, Veerle Melotte, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 21, 2014
Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer
Seth A Brodie, Ge Li, Adam El-Kommos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2013
CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC
Rathi N Pillai, Seth A Brodie, Gabriel L Sica, et al.
Page
of 5